WorkspaceResearch
HINOONPHARMACEUTICALSAlpha Score••Free accountSep-26

Highnoon Laboratories Ltd

Shariah compliant
Last close
Rs960.16
−0.47%
3 monthsAs of 19 Nov
BusinessStrongGrowthGrew 10%+last yearValueCore planHealthStrongDividendRising

A strong balance sheet, a dividend raised 6 years running and a strong business. No read is against it.

Working

  • Debt is 8% of equity in the latest quarter.
  • Revenue up 5% on the same quarter last year.
  • Yield 5.2% at today's price.

To watch

  • P/E 12.2 against a sector median of 11.9.
  • Rs 4.5bn owed by customers. Collections decide how much of the profit turns into cash.
  • Profit down 2% on the same quarter last year.
Full analysis · free account

Keep reading HINOON: business, price trend and value

How good the business is, where its support zone sits, what it may be worth, its health, dividends, peers and latest results open with a free account.

Latest results

Quarter: Jul–Sep 2026

In the Jul–Sep 2026 quarter, HINOON's sales rose 5% to Rs 7.5bn, from Rs 7.1bn, and profit after tax fell 2% to Rs 930.8mn, from Rs 945.2mn (compared with Jul–Sep 2025).

Earnings per share were Rs 17.57, against Rs 17.84 a year earlier.

At Rs 960.16, HINOON trades at 12.1 times earnings, with a dividend yield of 5.2%.

P/E ratio
12.1
Dividend yield
5.2%
Dividend payout
0%
of earnings
Return on equity
30%
Net margin
14.0%
last 12 months
Debt to equity
0.08

HINOON quarterly results

Reported figures
QuarterSalesProfit after taxNet marginEPSDividend / share
Jul–Sep 2026Rs 7.5bnRs 930.8mn12.4%Rs 17.57—
Apr–Jun 2026Rs 6.5bnRs 735.1mn11.4%Rs 13.87—
Jan–Mar 2026Rs 7.5bnRs 1.0bn13.9%Rs 19.78—
Oct–Dec 2025Rs 7.4bnRs 1.4bn19.6%Rs 27.32Rs 50.00
Jul–Sep 2025Rs 7.1bnRs 945.2mn13.3%Rs 17.84—
Apr–Jun 2025Rs 6.2bnRs 780.8mn12.7%Rs 14.74—
Jan–Mar 2025Rs 7.0bnRs 954.6mn13.6%Rs 18.02—
Oct–Dec 2024Rs 6.3bnRs 968.5mn15.3%Rs 18.27Rs 40.00

HINOON annual results and dividends

Reported figures
YearSalesProfit after taxEPSDividend / share
Year to Dec 2025Rs 27.7bnRs 4.1bnRs 77.92Rs 50.00
Year to Dec 2024Rs 24.6bnRs 3.4bnRs 63.95Rs 40.00
Year to Dec 2023Rs 19.4bnRs 2.4bnRs 45.35Rs 30.00
Year to Dec 2022Rs 15.8bnRs 2.4bnRs 45.62Rs 15.81
Year to Dec 2021Rs 13.0bnRs 1.8bnRs 34.12Rs 14.37

Balance sheet and price

Balance sheet as of Sep 2026
Total assets
Rs 19.8bn
Shareholders' equity
Rs 13.8bn
Cash & bank
Rs 1.0bn
Total debt
Rs 1.1bn
Current ratio
2.95
3-month high
Rs 1010.69
3-month low
Rs 905.20
1-month change
+2.4%
3-month change
-2.8%

Read more about HINOON

Other pharmaceuticals companies

HINOON: common questions

What is HINOON's share price?

Highnoon Laboratories Ltd (HINOON) last closed at Rs 960.16 on the Pakistan Stock Exchange.

Does HINOON pay a dividend?

Yes. Highnoon Laboratories Ltd paid Rs 50.00 per share for the year to Dec 2025, and the stock's dividend yield is 5.2%.

What were HINOON's latest results?

In the Jul–Sep 2026 quarter, HINOON's sales rose 5% to Rs 7.5bn, from Rs 7.1bn, and profit after tax fell 2% to Rs 930.8mn, from Rs 945.2mn (compared with Jul–Sep 2025).

What is HINOON's P/E ratio?

At Rs 960.16, HINOON trades at 12.1 times its earnings.

Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.